The consequences of heparin use in primary percutaneous coronary intervention: insights from the blue cross blue shield of michigan cardiovascular consortium (bmc2)

Prashanth S. Katrapati,Marta Bande,Milan Seth,Samer Kazziha,Mark Zainea,Simon Dixon,David Wohns, James Mitchiner,Hitinder Gurm

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2014）

引用 0|浏览8

暂无评分

摘要

Heparin is commonly used as the sole procedural anticoagulant in patients undergoing primary PCI (PPCI). Use of Bivalirudin compared with platelet glycoprotein IIbIIIa inhibitors (GPI) has been associated with improved survival in this cohort. There are no data on the comparative effectiveness of

查看译文

关键词

Treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要